Back to MORGAN STANLEY MORGAN STANLEY

GANXGANX
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in GAIN THERAPEUTICS INC

MORGAN STANLEY holds 125,972 shares of GANX (GAIN THERAPEUTICS INC), worth $255,723 as of 2026-Q2. The position was decreased (-9.8% shares).

Current Value

$255,723

Current Shares

125,972

Total Value Change

+$251,499

Total Shares Change

+122,672

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
125,972
-9.8%
$255,7230.0%$2.03
0
2026-Q1
Decreased
139,652
-5.4%
$270,9250.0%$2.63
0
2025-Q4
Decreased
147,591
-5.2%
$475,2440.0%$3.05
0
2025-Q3
Increased
155,675
+103.5%
$275,5450.0%$1.81
26
2025-Q2
Decreased
76,512
-23.3%
$137,7220.0%$1.97
0
2025-Q1
Increased
99,795
+12.8%
$190,6090.0%$1.89
17
2024-Q4
Increased
88,512
+1744.0%
$191,1860.0%$2.18
25
2024-Q3
Increased
4,800
+45.5%
$8,5440.0%$1.99
15
2024-Q2
New
3,300
-
$4,2240.0%$1.28
22

Other major holders of GANX: GREENLIGHT CAPITAL INC, Gotham Asset Management, LLC, MARSHALL WACE, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used